European Malignant Hyperthermia Group
  • About
  • News Meetings Education 2025 annual meeting
  • General Testing for MH Genetics PatientInformation
  • Recommendations
  • Grants
  • MH units
  • Contact
  • Links
  • Find
  • Sign In My Account
European Malignant Hyperthermia Group
  • About/
  • News & meetings/
    • News
    • Meetings
    • Education
    • 2025 annual meeting
  • Diagnosis/
    • General
    • Testing for MH
    • Genetics
    • PatientInformation
  • Recommendations/
  • Grants/
  • MH units/
  • Contact/
  • Links/
  • Find/
  • Sign InMy Account
European Malignant Hyperthermia Group

Recommendations

European Malignant Hyperthermia Group
  • About/
  • News & meetings/
    • News
    • Meetings
    • Education
    • 2025 annual meeting
  • Diagnosis/
    • General
    • Testing for MH
    • Genetics
    • PatientInformation
  • Recommendations/
  • Grants/
  • MH units/
  • Contact/
  • Links/
  • Find/
  • Sign InMy Account

Recommendations

In addition to the guidelines for MH diagnosis the European Malignant Hyperthermia Group has issued the following recommendations. 


Featured
Jan 6, 2025
Use of Penthrox (methoxyflurane)
Jan 6, 2025
Jan 6, 2025
Nov 4, 2024
Recognising and managing a malignant hyperthermia crisis (v2024)
Nov 4, 2024
Nov 4, 2024
May 9, 2024
Life insurance and MH
May 9, 2024
May 9, 2024
Jan 19, 2021
Perioperative management of known or suspected MHS
Jan 19, 2021
Jan 19, 2021
Aug 26, 2020
Dantrolene availability
Aug 26, 2020
Aug 26, 2020
Jul 28, 2020
Occupational exposure to volatile anaesthetics
Jul 28, 2020
Jul 28, 2020
May 20, 2019
Malignant hyperthermia during pregnancy
May 20, 2019
May 20, 2019
Feb 27, 2018
Perioperative Management of MH Suspected or Susceptible Patients
Feb 27, 2018
Feb 27, 2018
Feb 27, 2018
Preparation of Anaesthetic Workstations for MH suspected or susceptible patients
Feb 27, 2018
Feb 27, 2018
Dec 30, 2017
Management of MH crisis
Dec 30, 2017
Dec 30, 2017
Dec 30, 2017
in-vitro contracture testing
Dec 30, 2017
Dec 30, 2017

January 19, 2021

Perioperative management of known or suspected MHS

January 19, 2021/ Thierry Girard

We are pleased to announce publication of the EMHG guidance on perioperative management of malignant hyperthermia suspected or susceptible patients.

https://doi.org/10.1016/j.bja.2020.09.029

Screenshot 2021-01-19 at 13.04.57.png
January 19, 2021/ Thierry Girard/

Thierry Girard

  • Life insurance and MH
  • Dantrolene availability
  • About/
  • News & meetings/
    • News
    • Meetings
    • Education
    • 2025 annual meeting
  • Diagnosis/
    • General
    • Testing for MH
    • Genetics
    • PatientInformation
  • Recommendations/
  • Grants/
  • MH units/
  • Contact/
  • Links/
  • Find/
  • Sign InMy Account

European Malignant Hyperthermia Group

EMHG

The EMHG constitution
The Executive Committee
Quality Assurance Program
Membership
Contact us


signup for membership

Specialist society member

privacy policy